Your browser doesn't support javascript.
loading
[Influence of polymorphisms of VEGFR2 on clinical outcomes and safety of advanced non-small-cell lung cancer treated by first line Bevacizumab plus chemotherapy regimens].
Fan, H J; Yuan, J; Wu, J J; Jia, Y X; Ma, Y H; Li, X Y.
Afiliação
  • Fan HJ; Department of Oncology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
  • Yuan J; Department of Oncology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
  • Wu JJ; Department of Oncology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
  • Jia YX; Department of Oncology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
  • Ma YH; Department of Pathology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
  • Li XY; Department of Oncology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
Zhonghua Yi Xue Za Zhi ; 99(2): 99-104, 2019 Jan 08.
Article em Zh | MEDLINE | ID: mdl-30669746
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Pulmonar de Células não Pequenas Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: Zh Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Pulmonar de Células não Pequenas Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: Zh Ano de publicação: 2019 Tipo de documento: Article